combination therapy with osimertinib for egfr nsclc - targeted therapies in lung cancer 2023
Published 11 months ago • 90 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
6:26
metastatic egfr nsclc: recent developments - targeted therapies in lung cancer 2023
-
3:02
resistance mechanisms in egfr nsclc treatment - targeted therapies in lung cancer 2023
-
5:54
key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
-
2:11
neoadjuvant osimertinib and surgically resectable egfr - targeted therapies in lung cancer 2023
-
6:06
the adaura trial: the effect on egfr treatment - targeted therapies in lung cancer 2023
-
3:20
egfr mutated nsclc disease progression on osimertinib - 2022 program: targeted therapies forum
-
2:30
acquired resistance to osimertinib in egfr nsclc - 2022 program: targeted therapies forum - english
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
2:43
nrg1 fusions: treatment options - targeted therapies in lung cancer 2023
-
4:22
what is egfr in lung cancer? - 2022 program: targeted therapies forum
-
4:02
egfr resisters: an advocacy group - targeted therapies in lung cancer 2023
-
2:06
2020 ttf egfr qa panel updates combo treatment of osimertinib (tagrisso) & ramucirumab (cyramza)
-
6:00
the adaura trial: 2023 updates - targeted therapies in lung cancer 2023
-
5:07
q&a: what is the efficacy of amivantamab and lazertinib? - targeted therapies in lung cancer 2023
-
2:43
post-osimertinib treatment options for egfr nsclc - targeted therapies in lung cancer 2023
-
5:30:11
full event mainstage 2023 targeted therapies in lung cancer patient forum on-demand
-
6:39
q&a: how do i handle side effects? - targeted therapies in lung cancer 2023
-
8:49
grace targeted therapies lung cancer 2021 - a role for chemo io in patients with egfr mutations?
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021